{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:30Z","timestamp":1787771250942,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Medical University of Gdansk","award":["ST 01-30024\/0006078\/774\/2024"],"award-info":[{"award-number":["ST 01-30024\/0006078\/774\/2024"]}]},{"name":"Medical University of Gdansk","award":["ST 01-30024\/0006075\/773\/2024"],"award-info":[{"award-number":["ST 01-30024\/0006075\/773\/2024"]}]},{"name":"Medical University of Gdansk","award":["Support program for Experienced Researchers 2022 (second edition)"],"award-info":[{"award-number":["Support program for Experienced Researchers 2022 (second edition)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40121-024-01101-2","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:42:12Z","timestamp":1735238532000},"page":"305-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis\u00a0C After Treatment"],"prefix":"10.1007","volume":"14","author":[{"given":"Anna","family":"Wr\u00f3blewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Gliwi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Rybicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Cheba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Lorenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Trzonkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof P.","family":"Bielawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-5669","authenticated-orcid":false,"given":"Katarzyna","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"1101_CR1","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","volume":"393","author":"F Carrat","year":"2019","unstructured":"Carrat F, Fontaine H, Dorival C, et al. Clinical outcomes in patients with chronic hepatitis\u00a0C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019;393:1453\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(18)32111-1.","journal-title":"Lancet"},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3390\/jcm12062195","volume":"12","author":"EN Lynch","year":"2023","unstructured":"Lynch EN, Russo FP. Outcomes and follow-up after hepatitis\u00a0C eradication with direct-acting antivirals. J Clin Med. 2023;12:2195. https:\/\/doi.org\/10.3390\/jcm12062195.","journal-title":"J Clin Med"},{"key":"1101_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0973-6883(11)60130-8","volume":"1","author":"TN Pham","year":"2011","unstructured":"Pham TN, Michalak TI. Occult hepatitis\u00a0C virus infection and its relevance in clinical practice. J Clin Exp Hepatol. 2011;1:185\u20139. https:\/\/doi.org\/10.1016\/S0973-6883(11)60130-8.","journal-title":"J Clin Exp Hepatol"},{"key":"1101_CR4","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1111\/liv.12320","volume":"34","author":"MC Roque-Cu\u00e9llar","year":"2014","unstructured":"Roque-Cu\u00e9llar MC, S\u00e1nchez B, Garc\u00eda-Lozano JR, et al. Hepatitis\u00a0C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells. Liver Int. 2014;34:e80\u20138. https:\/\/doi.org\/10.1111\/liv.12320.","journal-title":"Liver Int"},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ebiom.2019.07.043","volume":"46","author":"Y Wang","year":"2019","unstructured":"Wang Y, Rao H, Chi X, et al. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality. EBioMedicine. 2019;46:227\u201335. https:\/\/doi.org\/10.1016\/j.ebiom.2019.07.043.","journal-title":"EBioMedicine"},{"key":"1101_CR6","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.3390\/jcm10245874","volume":"10","author":"A Wr\u00f3blewska","year":"2021","unstructured":"Wr\u00f3blewska A, Bielawski KP, Sikorska K. Occult infection with hepatitis\u00a0C virus: looking for clear-cut boundaries and methodological consensus. J Clin Med. 2021;10:5874. https:\/\/doi.org\/10.3390\/jcm10245874.","journal-title":"J Clin Med"},{"key":"1101_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10238-019-00561-y","volume":"19","author":"A Wr\u00f3blewska","year":"2019","unstructured":"Wr\u00f3blewska A, Lorenc B, Cheba M, Bielawski KP, Sikorska K. Neutrocyte-to-lymphocyte ratio predicts the presence of a replicative hepatitis\u00a0C virus strand after therapy with direct-acting antivirals. Clin Exp Med. 2019;19:401\u20136. https:\/\/doi.org\/10.1007\/s10238-019-00561-y.","journal-title":"Clin Exp Med"},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1111\/j.1365-2567.2008.03021.x","volume":"128","author":"A Sharma","year":"2009","unstructured":"Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis\u00a0C: implications for hepatitis\u00a0C virus pathogenesis. Immunology. 2009;128:e514\u201322. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03021.x.","journal-title":"Immunology"},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","volume":"214","author":"J Hengst","year":"2016","unstructured":"Hengst J, Falk CS, Schlaphoff V, et al. Direct-acting antiviral-induced hepatitis\u00a0C virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis\u00a0C. J Infect Dis. 2016;214:1965\u201374. https:\/\/doi.org\/10.1093\/infdis\/jiw457.","journal-title":"J Infect Dis"},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/gut.2010.232116","volume":"61","author":"ED Brennd\u00f6rfer","year":"2012","unstructured":"Brennd\u00f6rfer ED, Brass A, S\u00f6derholm J, et al. Hepatitis\u00a0C virus non-structural 3\/4A protein interferes with intrahepatic interferon-\u03b3 production. Gut. 2012;61:589\u201396. https:\/\/doi.org\/10.1136\/gut.2010.232116.","journal-title":"Gut"},{"key":"1101_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0753-3322(97)89432-2","volume":"51","author":"M Malaguarnera","year":"1997","unstructured":"Malaguarnera M, Di Fazio I, Laurino A, Pistone G, Restuccia S, Trovato BA. Decrease of interferon gamma serum levels in patients with chronic hepatitis\u00a0C. Biomed Pharmacother. 1997;51:391\u20136. https:\/\/doi.org\/10.1016\/s0753-3322(97)89432-2.","journal-title":"Biomed Pharmacother"},{"key":"1101_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41575-021-00444-2","volume":"18","author":"S Cao","year":"2021","unstructured":"Cao S, Liu M, Sehrawat TS, Shah VH. Regulation and functional roles of chemokines in liver diseases. Nat Rev Gastroenterol Hepatol. 2021;18:630\u201347. https:\/\/doi.org\/10.1038\/s41575-021-00444-2.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1101_CR13","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2009-12-256065","volume":"116","author":"RH Mounzer","year":"2010","unstructured":"Mounzer RH, Svendsen OS, Baluk P, et al. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood. 2010;116:2173\u201382. https:\/\/doi.org\/10.1182\/blood-2009-12-256065.","journal-title":"Blood"},{"key":"1101_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/ar3376","volume":"13","author":"F Calmon-Hamaty","year":"2011","unstructured":"Calmon-Hamaty F, Combe B, Hahne M, Morel J. Lymphotoxin \u03b1 revisited: general features and implications in rheumatoid arthritis. Arthritis Res Ther. 2011;13:232. https:\/\/doi.org\/10.1186\/ar3376.","journal-title":"Arthritis Res Ther"},{"key":"1101_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cytogfr.2018.12.001","volume":"45","author":"YM Mao","year":"2019","unstructured":"Mao YM, Zhao CN, Leng J, et al. Interleukin-13: a promising therapeutic target for autoimmune disease. Cytokine Growth Factor Rev. 2019;45:9\u201323. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.12.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jcmgh.2023.12.011","volume":"17","author":"J Rei\u00dfing","year":"2024","unstructured":"Rei\u00dfing J, Berres M, Strnad P, et al. Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13-dependent fibrogenesis. Cell Mol Gastroenterol Hepatol. 2024;17:517\u201338. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.12.011.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1101_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/09537104.2019.1571188","volume":"30","author":"K Mathur","year":"2019","unstructured":"Mathur K, Kurbanova N, Qayyum R. Platelet-lymphocyte ratio (PLR) and all-cause mortality in general population: insights from national health and nutrition education survey. Platelets. 2019;30:1036\u201341. https:\/\/doi.org\/10.1080\/09537104.2019.1571188.","journal-title":"Platelets"},{"key":"1101_CR18","doi-asserted-by":"publisher","first-page":"1376894","DOI":"10.3389\/fendo.2024.1376894","volume":"15","author":"C Yan","year":"2024","unstructured":"Yan C, Zhang W, Xiao Y, Sun Y, Peng X, Cai W. The predictive role of the platelet-to-lymphocyte ratio for the risk of non-alcoholic fatty liver disease and cirrhosis: a nationwide cross-sectional study. Front Endocrinol (Lausanne). 2024;15:1376894. https:\/\/doi.org\/10.3389\/fendo.2024.1376894.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1101_CR19","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.21037\/tcr-22-1197","volume":"11","author":"DZ Li","year":"2022","unstructured":"Li DZ, Guo J, Song QK, Hu XJ, Bao XL, Lu J. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Transl Cancer Res. 2022;11:4037\u201350. https:\/\/doi.org\/10.21037\/tcr-22-1197.","journal-title":"Transl Cancer Res"},{"key":"1101_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2016.02.025","volume":"45","author":"X Meng","year":"2016","unstructured":"Meng X, Wei G, Chang Q, et al. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis\u00a0C virus infection. Int J Infect Dis. 2016;45:72\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2016.02.025.","journal-title":"Int J Infect Dis"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01101-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-01101-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01101-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:58:56Z","timestamp":1738216736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-01101-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-01101-2","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anna Wr\u00f3blewska, Mateusz Gliwi\u0144ski, Magda Rybicka, Ma\u0142gorzata Cheba, Beata Lorenc, Piotr Trzonkowski, Krzysztof P. Bielawski, and Katarzyna Sikorska declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments. The study protocol was approved by the Local Independent Bioethics Committee at the Medical University of Gdansk (NKBBN 852\/2021, NKEB 246\/2011, NKBBN 178\/2023). Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}